Stock of Interest

Posted On: July 3, 2023

Stock Report : ALKEM (NSE) 3 Jul 2023

Outlook: Bullish

Alkem Laboratories Ltd. is a pharmaceutical company that operates in the development, manufacturing, and marketing of a wide range of healthcare products. With a strong emphasis on quality, innovation, and affordability, the company specializes in branded generics, over-the-counter drugs, and active pharmaceutical ingredients. Alkem focuses on various therapeutic areas such as anti-infectives, gastroenterology, pain management, cardiovascular, and neurology. Committed to improving global healthcare, Alkem Laboratories aims to provide high-quality and accessible pharmaceutical solutions to enhance the well-being of individuals around the world.

xCalData identifies ALKEM will continue its BULLISH phase in the next 5 days and trend in the range of 3574 and 3427         

ALKEM has shown consistent positive returns in the past periods.

We see the stock has  doubled once in the past.

xCalData offers unbiased insights into stocks. Download the app from google play. For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData

Disclaimer: The securities quoted are for illustration only and are not recommendatory